首页|期刊导航|国际肝胆胰疾病杂志（英文版）|Synergistic interaction between thioredoxin inhibitor 1-methylpropyl 2-imidazolyl disulfide and sorafenib in liver cancer cells

Synergistic interaction between thioredoxin inhibitor 1-methylpropyl 2-imidazolyl disulfide and sorafenib in liver cancer cells

Lin-Ping Cao Chen Zhang Xiao-Yu Weng Hai-Yang Xie Jian Wu Shu-Sen Zheng

国际肝胆胰疾病杂志（英文版）2020，Vol.19Issue(3)：295-298,4.

Synergistic interaction between thioredoxin inhibitor 1-methylpropyl 2-imidazolyl disulfide and sorafenib in liver cancer cells

Lin-Ping Cao ¹Chen Zhang ²Xiao-Yu Weng ¹Hai-Yang Xie ²Jian Wu ¹Shu-Sen Zheng²

作者信息

1. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
2. Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou 310003, China
折叠

摘要

引用本文复制引用

Lin-Ping Cao,Chen Zhang,Xiao-Yu Weng,Hai-Yang Xie,Jian Wu,Shu-Sen Zheng..Synergistic interaction between thioredoxin inhibitor 1-methylpropyl 2-imidazolyl disulfide and sorafenib in liver cancer cells[J].国际肝胆胰疾病杂志（英文版）,2020,19(3):295-298,4.

基金项目

This study was supported by grants from the National Natural Science Foundation of China ( 81874228 ) and the Science and Tech- nology Department of Zhejiang Province( 2015C03034 ). （ 81874228 ）

国际肝胆胰疾病杂志（英文版）

OACSCDSCI

ISSN：1499-3872

访问量0

下载量0

段落导航